Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mapping carbon accumulation potential from global natural forest regrowth.
Cook-Patton SC, Leavitt SM, Gibbs D, Harris NL, Lister K, Anderson-Teixeira KJ, Briggs RD, Chazdon RL, Crowther TW, Ellis PW, Griscom HP, Herrmann V, Holl KD, Houghton RA, Larrosa C, Lomax G, Lucas R, Madsen P, Malhi Y, Paquette A, Parker JD, Paul K, Routh D, Roxburgh S, Saatchi S, van den Hoogen J, Walker WS, Wheeler CE, Wood SA, Xu L, Griscom BW. Cook-Patton SC, et al. Among authors: larrosa c. Nature. 2020 Sep;585(7826):545-550. doi: 10.1038/s41586-020-2686-x. Epub 2020 Sep 23. Nature. 2020. PMID: 32968258
Conservation. A double-edged sword for tropical forests.
Carrasco LR, Larrosa C, Milner-Gulland EJ, Edwards DP. Carrasco LR, et al. Among authors: larrosa c. Science. 2014 Oct 3;346(6205):38-40. doi: 10.1126/science.1256685. Epub 2014 Oct 2. Science. 2014. PMID: 25278600 No abstract available.
Tropical crops: cautious optimism--response.
Carrasco LR, Larrosa C, Milner-Gulland EJ, Edwards DP. Carrasco LR, et al. Among authors: larrosa c. Science. 2014 Nov 21;346(6212):928. doi: 10.1126/science.346.6212.928-b. Epub 2014 Nov 20. Science. 2014. PMID: 25414295 No abstract available.
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes.
Muñoz JP, Larrosa C, Chamorro S, Perez-Jaume S, Simao M, Sanchez-Sierra N, Varo A, Gorostegui M, Castañeda A, Garraus M, Lopez-Miralles S, Mora J. Muñoz JP, et al. Among authors: larrosa c. Cancers (Basel). 2023 Oct 3;15(19):4837. doi: 10.3390/cancers15194837. Cancers (Basel). 2023. PMID: 37835531 Free PMC article.
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report.
Mora J, Castañeda A, Gorostegui M, Varo A, Perez-Jaume S, Simao M, Muñoz JP, Garraus M, Larrosa C, Salvador N, Lavarino C, Krauel L, Mañe S. Mora J, et al. Among authors: larrosa c. Cancers (Basel). 2023 Apr 28;15(9):2535. doi: 10.3390/cancers15092535. Cancers (Basel). 2023. PMID: 37174002 Free PMC article.
12 results